Literature DB >> 2173254

Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.

M Elleder1, V Bradová, F Smíd, M Budĕsínský, K Harzer, B Kustermann-Kuhn, J Ledvinová, V Král, V Dorazilová.   

Abstract

Fabry's disease was diagnosed in an adult patient as a lipid storage-induced non-obstructive hypertrophic cardiomyopathy. Stable angina pectoris started 15 years before death, was followed by slowly progressive heart failure and repeated pulmonary thromboembolism with death at 63 years. Autopsy disclosed enormous cardiomegaly (1100 g), cardiac storage of ceramide trihexoside (CTH) of the same intensity as in classical cases of generalized Fabry's disease (11 mg lipid/g wet weight) restricted to cardiocytes. Other tissues (liver, kidney, brain, pancreas, pulmonary artery, coronary arteries) were free of storage. Using proton magnetic resonance analysis on formaldehyde-fixed tissue the stored CTH was identified as globotriaosylceramide. It was enzymatically degradable by control cell cultures but left uncleaved by mutant reference Fabry cells. Alpha-galactosidase activities in peripheral leucocytes of all four of the patient's daughters were in the heterozygous range. The diagnostic difficulties in this monosymptomatic novel variant of Fabry's disease are stressed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173254     DOI: 10.1007/BF01606034

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  17 in total

1.  [Secondary hypertrophic, obstructive cardiomyopathy in Fabry's disease].

Authors:  P Fritz; H Schneider; P Heimburg; G Wegner
Journal:  Med Welt       Date:  1978-11-24

2.  Two dimensional echocardiographic similarity of Fabry's disease to cardiac amyloidosis: a function of ultrastructural analogy?

Authors:  I S Cohen; J Fluri-Lundeen; T P Wharton
Journal:  J Clin Ultrasound       Date:  1983-10       Impact factor: 0.910

3.  Hypertrophic obstructive cardiomyopathy due to Fabry's disease.

Authors:  W S Colucci; B H Lorell; F J Schoen; M J Warhol; W Grossman
Journal:  N Engl J Med       Date:  1982-10-07       Impact factor: 91.245

4.  [The heart in Fabry's disease].

Authors:  J M Mossard; G Jossot; L S Wolfe; A Batzenschlager; P Stoebner; H Metzger
Journal:  Arch Mal Coeur Vaiss       Date:  1972-04

5.  On the pathology of angiokeratoma corporis diffusum (Fabry).

Authors:  E Jensen
Journal:  Acta Pathol Microbiol Scand       Date:  1966

6.  A case of heterozygous Fabry's disease with a short PR interval and giant negative T waves.

Authors:  A Yokoyama; M Yamazoe; A Shibata
Journal:  Br Heart J       Date:  1987-03

7.  Structural analysis of glycosphinoglipids by high-resolution 1H nuclear magnetic resonance spectroscopy.

Authors:  J Dabrowski; P Hanfland; H Egge
Journal:  Biochemistry       Date:  1980-11-25       Impact factor: 3.162

8.  [Fabry's disease. Light and electron microscopic cardiac findings 12 years after successful kidney transplantation].

Authors:  F Bannwart
Journal:  Schweiz Med Wochenschr       Date:  1982-11-27

9.  Lysosomal non-lipid component of Gaucher's cells.

Authors:  M Elleder; F Smíd
Journal:  Virchows Arch B Cell Pathol       Date:  1977-12-30

10.  Characterization and quantitative determination of gangliosides and neutral glycosphingolipids in human liver.

Authors:  O Nilsson; L Svennerholm
Journal:  J Lipid Res       Date:  1982-02       Impact factor: 5.922

View more
  46 in total

1.  The natural history of left ventricular systolic function in Anderson-Fabry disease.

Authors:  J S Shah; P Lee; D Hughes; R Thaman; B Sachdev; D Pellerin; A Mehta; P M Elliott
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

2.  Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes.

Authors:  Fumiko Matsuzawa; Sei-ichi Aikawa; Hirofumi Doi; Toshika Okumiya; Hitoshi Sakuraba
Journal:  Hum Genet       Date:  2005-05-28       Impact factor: 4.132

3.  Effective clearance of GL-3 in a human iPSC-derived cardiomyocyte model of Fabry disease.

Authors:  Jean-Michel Itier; Gwénaëlle Ret; Sandra Viale; Lindsay Sweet; Dinesh Bangari; Anne Caron; Françoise Le-Gall; Bernard Bénichou; John Leonard; Jean-François Deleuze; Cécile Orsini
Journal:  J Inherit Metab Dis       Date:  2014-05-22       Impact factor: 4.982

Review 4.  Genetics of inherited cardiomyopathy.

Authors:  Daniel Jacoby; William J McKenna
Journal:  Eur Heart J       Date:  2011-08-02       Impact factor: 29.983

Review 5.  Cardiac manifestations in Fabry disease.

Authors:  A Linhart; J C Lubanda; T Palecek; J Bultas; D Karetová; J Ledvinová; M Elleder; M Aschermann
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

6.  Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity.

Authors:  Justina C Wu; Carolyn Y Ho; Hicham Skali; Rekha Abichandani; William R Wilcox; Maryam Banikazemi; Seymour Packman; Katherine Sims; Scott D Solomon
Journal:  Eur Heart J       Date:  2010-01-07       Impact factor: 29.983

7.  Sisters with atypical Fabry's disease with complete atrioventricular block.

Authors:  Y Doi; G Toda; K Yano
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

8.  Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.

Authors:  Satoshi Ishii; Shoichiro Nakao; Reiko Minamikawa-Tachino; Robert J Desnick; Jian-Qiang Fan
Journal:  Am J Hum Genet       Date:  2002-02-04       Impact factor: 11.025

9.  Leptomeningeal lipid storage patterns in Fabry disease.

Authors:  M Elleder; H Christomanou; B Kustermann-Kuhn; K Harzer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Intravascular ultrasound assessment of coronary artery involvement in Fabry disease.

Authors:  T Kovarnik; G S Mintz; D Karetova; J Horak; J Bultas; R Skulec; H Skalicka; M Aschermann; M Elleder; A Linhart
Journal:  J Inherit Metab Dis       Date:  2008-11-08       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.